Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Clinical trial NCT06506838 · RECRUITING
Trial details
- NCT number
- NCT06506838
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-10
- Primary completion
- 2027-07-20
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.